Human Immunodeficiency Virus and Breastfeeding: Clinical Considerations and Mechanisms of Transmission in the Modern Era of Combined Antiretroviral Therapy
- PMID: 39487020
- PMCID: PMC11558571
- DOI: 10.1016/j.clp.2024.08.001
Human Immunodeficiency Virus and Breastfeeding: Clinical Considerations and Mechanisms of Transmission in the Modern Era of Combined Antiretroviral Therapy
Abstract
Combined antiretroviral therapy has significantly reduced perinatal human immunodeficiency virus (HIV) transmission risk through breastfeeding, prompting shifts in clinical guidance to support breastfeeding for women with HIV who have sustained viral suppression. This review examines the current evidence on HIV transmission via breast milk, including risk factors, mechanisms, and risk reduction strategies to inform patient-centered and evidence-driven clinical care.
Keywords: Antiretroviral therapy (ART); Breastfeeding; HIV; Risk reduction.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure All authors declare no financial conflicts of interest.
References
-
- Flynn PM, Taha TE, Cababasay M, et al. Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial. J Acquir Immune Defic Syndr. 2018;77(4):383–392. doi:10.1097/QAI.0000000000001612 - DOI - PMC - PubMed
-
- Davis NL, Corbett A, Kaullen J, et al. Antiretroviral Drug Concentrations in Breastmilk, Maternal HIV Viral Load, and HIV Transmission to the Infant: Results From the BAN Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2019;80(4):467–473. doi:10.1097/QAI.0000000000001941 - DOI - PMC - PubMed
